V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220005633 | 220002204 | 1.92 | 74.6 | Curative (C) | 2013-01-16 | 2013-02-06 | AML17 TRIAL | Y | N | 220028630 | AML17 TRIAL |
| 220005634 | 220002204 | 1.72 | 57.2 | Disease modification (D) | 2013-06-13 | 2013-06-22 | Trial Unspecified | Y | N | 220028630 | TRIAL |
| 220005635 | 220021224 | 1.75 | 71.2 | Not known (9) | 2013-12-11 | 2013-12-11 | AML17 TRIAL | 02 | N | 220028639 | AML17 TRIAL |
| 220005636 | 220021224 | 1.58 | null | Palliative (P) | 2015-08-11 | 2015-08-14 | Cytarabine low (10to20mg/m2) IV/SC | N | null | 220028639 | CYTARABINE |
| 220005638 | 220002206 | null | 59.6 | Curative (C) | 2016-02-15 | 2016-02-19 | AML17 TRIAL | 01 | N | 220028644 | AML17 TRIAL |
| 220005641 | 220002208 | 1.67 | 84.8 | Disease modification (D) | 2015-01-23 | 2015-01-23 | LI-1 TRIAL | N | N | 220028649 | TRIAL |
| 220005642 | 220002208 | 1.65 | 68 | Curative (C) | 2018-03-27 | 2018-03-27 | AML17 TRIAL | 01 | N | 220028649 | AML17 TRIAL |
| 220005643 | 220002208 | null | 53.7 | Curative (C) | 2016-08-18 | 2016-08-22 | AML17 TRIAL | N | N | 220028649 | AML17 TRIAL |
| 220005644 | 220002208 | null | 62.3 | null | 2016-10-11 | 2016-10-17 | Trial Unspecified | Y | N | 220028649 | TRIAL |
| 220005645 | 220002209 | 1.68 | 59.7 | Curative (C) | 2014-03-16 | 2014-03-16 | AML17 TRIAL | 01 | N | 220028662 | AML17 TRIAL |
| 220005646 | 220002210 | null | null | Palliative (P) | 2013-09-13 | 2014-09-19 | Cytarabine Low Dose | N | N | 220028663 | CYTARABINE |
| 220005647 | 220002211 | 1.75 | 60 | Curative (C) | 2014-12-03 | 2014-12-03 | AML17 TRIAL | Y | N | 220028665 | AML17 TRIAL |
| 220005648 | 220002211 | 1.64 | 84.5 | Curative (C) | 2017-07-24 | 2017-07-24 | AML17 TRIAL | 1 | N | 220028665 | AML17 TRIAL |
| 220005649 | 220002211 | 1.85 | 0 | Palliative (P) | null | 2017-08-25 | Cytarabine Low Dose | 02 | N | 220028665 | CYTARABINE |
| 220005650 | 220002211 | 1.7 | null | Curative (C) | 2015-05-08 | 2015-05-10 | AML17 TRIAL | Y | N | 220028665 | AML17 TRIAL |
| 220005651 | 220002212 | 1.8 | 95.2 | Palliative (P) | 2014-11-24 | 2014-12-18 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220028671 | CYTARABINE |
| 220005652 | 220002213 | 1.82 | 71.5 | Adjuvant (A) | 2014-05-11 | 2014-05-11 | LI-1 TRIAL | Y | N | 220028673 | TRIAL |
| 220005653 | 220011213 | 1.85 | 70.3 | Palliative (P) | 2014-11-04 | 2016-05-20 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220028675 | CYTARABINE |
| 220005654 | 220016006 | 1.56 | null | null | 2014-11-02 | 2014-11-02 | Trial Unspecified | Y | N | 220028676 | TRIAL |
| 220005655 | 220002214 | 1.83 | null | Palliative (P) | 2013-03-15 | 2013-04-03 | Cytarabine Intrathecal (any age) | N | N | 220028677 | CYTARABINE |
| 220005656 | 220002215 | null | null | null | 2016-01-14 | 2016-01-17 | Cytarabine Low Dose | 2 | N | 220028679 | CYTARABINE |
| 220005657 | 220002215 | 1.58 | 0 | Palliative (P) | null | 2016-03-05 | CYTARABINE | null | null | 220028679 | CYTARABINE |
| 220005658 | 220002216 | null | 0 | null | 2016-12-16 | 2016-12-27 | Cytarabine Low Dose | N | null | 220028683 | CYTARABINE |
| 220005659 | 220002216 | 1.77 | 52.2 | Curative (C) | 2013-10-19 | 2013-10-19 | AML17 TRIAL | null | null | 220028683 | AML17 TRIAL |
| 220005660 | 220016007 | 1.59 | 45.7 | null | 2014-01-22 | 2014-01-28 | Cytarabine Low Dose | N | N | 220028685 | CYTARABINE |
| 220005661 | 220002217 | 1.73 | 74.6 | Curative (C) | 2016-08-31 | 2016-08-31 | AML17 TRIAL | Y | N | 220028687 | AML17 TRIAL |
| 220005662 | 220002218 | 1.75 | null | Palliative (P) | 2015-05-22 | 2015-05-22 | Trial Unspecified | Y | N | 220028689 | TRIAL |
| 220005663 | 220002218 | null | 65 | null | 2016-07-05 | 2016-07-10 | Cytarabine Low Dose | 02 | null | 220028689 | CYTARABINE |
| 220005664 | 220002218 | 1.75 | 70 | Curative (C) | 2015-09-25 | 2015-10-01 | Cytarabine Low Dose | N | Y | 220028689 | CYTARABINE |
| 220005665 | 220002219 | 1.82 | 60 | Palliative (P) | 2019-03-19 | 2019-03-19 | Cytarabine Low Dose | null | null | 220028694 | CYTARABINE |
| 220005666 | 220011217 | 1.77 | 7 | Palliative (P) | 2015-04-07 | 2015-04-07 | Cytarabine Low Dose | N | N | 220028695 | CYTARABINE |
| 220005667 | 220011217 | 1.67 | null | Disease modification (D) | 2014-05-07 | 2014-05-07 | Cytarabine Low Dose | N | N | 220028695 | CYTARABINE |
| 220005668 | 220002220 | 1.57 | 95.4 | Curative (C) | 2015-08-04 | 2015-08-10 | Trial Unspecified | 1 | N | 220028704 | TRIAL |
| 220005669 | 220002220 | null | 108.4 | Disease modification (D) | 2017-01-06 | 2017-01-06 | LI-1 TRIAL | Y | N | 220028704 | TRIAL |
| 220005670 | 220002220 | null | 78 | Curative (C) | null | 2016-05-01 | Trial Unspecified | Y | N | 220028704 | TRIAL |
| 220005671 | 220002220 | 1.72 | 59.7 | Not known (9) | 2016-06-17 | 2016-07-06 | AML17 TRIAL | N | N | 220028704 | AML17 TRIAL |
| 220005672 | 220002221 | null | null | Curative (C) | 2014-06-12 | 2014-06-12 | Trial Unspecified | 1 | N | 220028709 | TRIAL |
| 220005673 | 220002221 | 0 | 54.8 | Not known (9) | 2014-05-06 | 2014-05-08 | AML17 TRIAL | N | N | 220028709 | AML17 TRIAL |
| 220005674 | 220002221 | null | 60 | null | 2015-09-19 | 2015-10-05 | Trial Unspecified | Y | N | 220028709 | TRIAL |
| 220005675 | 220002221 | null | 58.8 | null | 2015-06-30 | 2015-07-07 | CYTARABINE | N | N | 220028709 | CYTARABINE |
| 220005676 | 220002221 | 1.78 | null | null | 2013-06-08 | 2013-06-08 | Cytarabine Low Dose | Y | null | 220028709 | CYTARABINE |
| 220005677 | 220002221 | 1.73 | 54 | Disease modification (D) | null | 2016-08-20 | LI-1 TRIAL | N | N | 220028709 | TRIAL |
| 220005678 | 220002221 | 1.73 | null | null | 2013-06-19 | 2013-06-19 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220028709 | CYTARABINE |
| 220005680 | 220002223 | 0 | 0 | Palliative (P) | 2013-04-10 | 2013-04-11 | CYTARABINE | 02 | N | 220028723 | CYTARABINE |
| 220005681 | 220002224 | 1.69 | 70.4 | Curative (C) | 2013-05-18 | 2013-05-20 | Trial Unspecified | Y | N | 220028724 | TRIAL |
| 220005682 | 220002225 | 1.75 | 87 | Curative (C) | 2013-09-21 | 2013-09-22 | AML17 TRIAL | N | N | 220028725 | AML17 TRIAL |
| 220005684 | 220002226 | null | null | Curative (C) | 2017-04-26 | 2017-04-26 | Trial Unspecified | Y | N | 220028729 | TRIAL |
| 220005685 | 220002226 | null | null | Palliative (P) | 2013-05-09 | 2013-05-09 | Cytarabine Low Dose | 02 | N | 220028729 | CYTARABINE |
| 220005686 | 220002226 | 1.49 | 68 | Curative (C) | 2016-05-07 | 2016-05-07 | Trial Unspecified | Y | null | 220028729 | TRIAL |
| 220005687 | 220002227 | 1.77 | 83.3 | Disease modification (D) | 2015-03-22 | 2015-03-22 | Trial Unspecified | N | N | 220028735 | TRIAL |